rhinosinusitis
Novartis’ Xolair scores European approval to treat chronic rhinosinusitis with nasal polyps
August 6, 2020Sales and Marketing Novartis, Xolair, rhinosinusitis
Novartis has snapped up approval from the European Commission for its anti-immunoglobulin E (IgE) antibody therapy Xolair (omalizumab) for the …
FDA approves Dupixent for chronic rhinosinusitis with nasal polyposis
June 27, 2019Sales and Marketing Dupixent, FDA, Sanofi, US, pharma, rhinosinusitis
Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in …
Sanofi’s Dupixent improves symptoms in rhinosinusitis with nasal polyps at Phase 3
February 27, 2019Research and Development Dupixent, Sanofi, pharma, rhinosinusitis
New data has been released on Sanofi’s Dupixent (dupilumab), derived from two Phase 3 trials, illustrating the drug’s efficacy In …
Latest content
Five Facts about cardiovascular disease
August 9, 2026
